A benzocaine lawsuit may be an option if you or someone you love was diagnosed with methemoglobinemia following administration of Orajel or another benzocaine-based oral pain medication.
Bernstein Liebhard LLP is investigating legal claims on behalf of individuals who were diagnosed with methemoglobinemia following treatment with an over-the-counter benzocaine medication. To contact an experienced benzocaine attorney for a free legal review, please call (888) 994-5118.
Benzocaine is the active ingredient in many drugs used to treat mouth pain, including the following OTC remedies:
In May 2016, the U.S. Food & Drug Administration (FDA) asked the manufacturers of benzocaine-based teething medications to stop marketing the products for use in children under the age of 2, after benzocaine was linked to hundreds of cases of methemoglobinemia, a potentially deadly blood disorder.
The agency also asked the makers of other benzocaine-containing oral pain medications to modify their product labels to warn of this potential risk.
“We estimate that more than 400 cases of benzocaine-associated methemoglobinemia have been reported to FDA* or published in the medical literature since 1971,” the FDA state. “There are likely additional cases about which we are unaware.”
People with methemoglobinemia experience a dangerous drop in blood oxygen levels. The potentially life-threatening disorder can be triggered by certain medications, toxins, and foods.
Babies are especially susceptible to methemoglobinemia. Patients who have breathing problems such as asthma, bronchitis, or emphysema; heart disease; the elderly; and those who smoke are at greater risk for complications if they develop the disorder.
Early methemoglobinemia symptoms may include:
As their condition worsens, patients may experience:
Signs and symptoms of methemoglobinemia may appear within minutes to one to two hours after exposure to benzocaine. Symptoms may occur after using benzocaine for the first time, as well as after prior uses.
Without timely treatment, severe methemoglobinemia can result in death.
According to the FDA:
You may be entitled to compensation if you or someone you love were diagnosed with methemoglobinemia following exposure to a benzocaine-based oral pain medication. To learn more about filing a benzocaine lawsuit, please call (888) 994-5118.
Get the latest news and litigation updates about this case by following us on Facebook. Click the "Like" button below.